Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Mautner

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Plos Pathogens|May 24, 2014
Virus and autoantigen-specific CD4+ T cells are key effectors in a SCID mouse model of EBV-associated post-transplant lymphoproliferative disordersStefanie Linnerbauer, Uta Behrends, Dinesh Adhikary, et al.
European Journal of Immunology|July 16, 2008
Endogenous presentation of a nuclear antigen on MHC class II by autophagy in the absence of CRM1-mediated nuclear exportAlexander Riedel, Falk Nimmerjahn, Stefan Burdach, et al.
Vaccine|September 22, 2014
Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infectionAmir Ghasemi, Mahmood Jeddi-Tehrani, Josef Mautner, et al.
The Journal of Experimental Medicine|March 22, 2006
Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteinsDinesh Adhikary, Uta Behrends, Andreas Moosmann, et al.
Journal of Virology|November 6, 2009
Epstein-Barr viruses that express a CD21 antibody provide evidence that gp350's functions extend beyond B-cell surface bindingClemens Busse, Regina Feederle, Martina Schnölzer, et al.
Journal of Virology|February 27, 2009
Primary B-cell infection with a deltaBALF4 Epstein-Barr virus comes to a halt in the endosomal compartment yet still elicits a potent CD4-positive cytotoxic T-cell responseBernhard Neuhierl, Regina Feederle, Dinesh Adhikary, et al.
Vaccine|July 26, 2018
Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infectionAmir Ghasemi, Nazanin Mohammad, Josef Mautner, et al.
Plos Pathogens|May 30, 2013
Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasionStefanie Ameres, Josef Mautner, Fabian Schlott, et al.
Frontiers in Immunology|January 3, 2022
Immunoinformatic Analysis Reveals Antigenic Heterogeneity of Epstein-Barr Virus Is Immune-DrivenAna Cirac, Remy Poirey, Michael Dieckmeyer, et al.
Journal of Virology|May 30, 2025
Assessing the fitness of Epstein-Barr virus following its reactivationYen-Fu Adam Chen, Bianca Mocanu, Ezgi Akidil, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Plos Pathogens|May 24, 2014
Virus and autoantigen-specific CD4+ T cells are key effectors in a SCID mouse model of EBV-associated post-transplant lymphoproliferative disordersStefanie Linnerbauer, Uta Behrends, Dinesh Adhikary, et al.
European Journal of Immunology|July 16, 2008
Endogenous presentation of a nuclear antigen on MHC class II by autophagy in the absence of CRM1-mediated nuclear exportAlexander Riedel, Falk Nimmerjahn, Stefan Burdach, et al.
Vaccine|September 22, 2014
Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infectionAmir Ghasemi, Mahmood Jeddi-Tehrani, Josef Mautner, et al.
The Journal of Experimental Medicine|March 22, 2006
Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteinsDinesh Adhikary, Uta Behrends, Andreas Moosmann, et al.
Journal of Virology|November 6, 2009
Epstein-Barr viruses that express a CD21 antibody provide evidence that gp350's functions extend beyond B-cell surface bindingClemens Busse, Regina Feederle, Martina Schnölzer, et al.
Journal of Virology|February 27, 2009
Primary B-cell infection with a deltaBALF4 Epstein-Barr virus comes to a halt in the endosomal compartment yet still elicits a potent CD4-positive cytotoxic T-cell responseBernhard Neuhierl, Regina Feederle, Dinesh Adhikary, et al.
Vaccine|July 26, 2018
Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infectionAmir Ghasemi, Nazanin Mohammad, Josef Mautner, et al.
Plos Pathogens|May 30, 2013
Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasionStefanie Ameres, Josef Mautner, Fabian Schlott, et al.
Frontiers in Immunology|January 3, 2022
Immunoinformatic Analysis Reveals Antigenic Heterogeneity of Epstein-Barr Virus Is Immune-DrivenAna Cirac, Remy Poirey, Michael Dieckmeyer, et al.
Journal of Virology|May 30, 2025
Assessing the fitness of Epstein-Barr virus following its reactivationYen-Fu Adam Chen, Bianca Mocanu, Ezgi Akidil, et al.
Pageof 8